Analysis of thymic generation of shared T‐cell receptor α repertoire associated with recognition of tumor antigens shows no preference for neoantigens over wild‐type antigens
Cancer Medicine · 2023
DOI: 10.1002/cam4.6002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Joonatan Mattila und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Programs Unit, Translational Immunology, Haartmaninkatu 3 (PL 21) 00014, and Medicum, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Thymus Gland, Antigens, Neoplasm, Neoplasms, Immune Tolerance. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lastentautien Tutkimussäätiö, Suomen Lääketieteen Säätiö, Waldemar von Frenckells Stiftelse.
Abstract (Originalsprache)
Background
The number of mutations in cancer cells is an important predictor of a positive response to cancer immunotherapy. It has been suggested that the neoantigens produced by these mutations are more immunogenic than nonmutated tumor antigens, which are likely to be protected by immunological tolerance. However, the mechanisms of tolerance as regards tumor antigens are incompletely understood.
Methods
Here, we have analyzed the impact of thymic negative selection on shared T‐cell receptor (TCR) repertoire associated with the recognition of either mutated or nonmutated tumor antigens by comparing previously known TCR—antigen—pairs to TCR repertoires of 21 immunologically healthy individuals.
Results
Our results show that TCRα chains associated with either type of tumor antigens are readily generated in the thymus, at a frequency similar to TCRα chains associated with nonself. In the peripheral repertoire, the relative clone size of nonself‐associated chains is higher than that of the tumor antigens, but importantly, there is no difference between TCRα chains associated with mutated or nonmutated tumor antigens.
Conclusion
This suggests that the tolerance mechanisms protecting nonmutated tumor antigens are non‐deletional and therefore potentially reversible. As unmutated antigens are, unlike mutations, shared by a large number of patients, they may offer advantages in designing immunological approaches to cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Programs Unit, Translational Immunology, Haartmaninkatu 3 (PL 21) 00014, and Medicum, University of Helsinki, Helsinki, Finland.
- Department of Computer Science, Aalto University, Espoo, Finland.
- Faculty of Medicine, Center for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
- Department of Pediatric Cardiac and Transplantation Surgery, Hospital for Children and Adolescents, Helsinki University Central Hospital, Helsinki, Finland.
ORCID-Profile: Joonatan Mattila
Förderung
- Lastentautien Tutkimussäätiö
- Suomen Lääketieteen Säätiö
- Waldemar von Frenckells Stiftelse
Zitieren
APA
Mattila, J., Sormunen, S., Heikkilä, N., Mattila, I. P., Saramäki, J., & Arstila, T. P. (2023). Analysis of thymic generation of shared T‐cell receptor α repertoire associated with recognition of tumor antigens shows no preference for neoantigens over wild‐type antigens. Cancer Medicine. https://doi.org/10.1002/cam4.6002
Vancouver
Mattila J, Sormunen S, Heikkilä N, Mattila IP, Saramäki J, Arstila TP. Analysis of thymic generation of shared T‐cell receptor α repertoire associated with recognition of tumor antigens shows no preference for neoantigens over wild‐type antigens. Cancer Medicine. 2023. doi:10.1002/cam4.6002
BibTeX
@article{Mattila2023,
author = {Mattila, Joonatan and Sormunen, Silja and Heikkilä, Nelli and Mattila, Ilkka P and Saramäki, Jari and Arstila, T Petteri},
title = {Analysis of thymic generation of shared T‐cell receptor α repertoire associated with recognition of tumor antigens shows no preference for neoantigens over wild‐type antigens},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6002}
}
EUVIMED